Abstract
Despite advances in the enzymology, molecular genetics, and clinical knowledge of the primary hyperoxalurias, few treatments are available. Oxalobacter formigenes is a promising new therapy with potential to induce secretion of oxalate into the intestinal lumen, where it can be degraded by the bacteria. © 2006 International Society of Nephrology.
Cite
CITATION STYLE
APA
Milliner, D. (2006, October 9). Treatment of the primary hyperoxalurias: A new chapter. Kidney International. Nature Publishing Group. https://doi.org/10.1038/sj.ki.5001821
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free